Allergy AI for allergists, with the clinician in charge.

Structured notes that understand allergy, testing documented in the same record, and every output reviewed by a person.

14-day free trial, no card to start. Then $99 per provider per month.

Advance AI LLC, the company behind Medora
Advance AI LLC is an OpenAI Select Partner
NVIDIA Inception member

Assistive by design.

Medora drafts and suggests; the clinician decides. Nothing is final without a person.

  • Every note is reviewed and signed by the clinician
  • Every skin-test value is confirmed by a person
  • Cross-reactivity alerts are advisory

Every line has a source.

Evidence Mapping links each line of the note to the moment in the visit it came from.

Why we built Medora

Pankaj Sabharwal, founder, on why allergy needs its own system, and what one system for the whole allergy practice looks like.

Questions about allergy AI

What is allergy AI?

Software built for the allergy visit: documentation that knows the terminology, testing documented in the same record, and patient context across visits.

Does it replace the allergist or nurse?

No. Medora drafts and suggests; the clinician reviews, edits and signs every note. Medora does not diagnose, order tests, prescribe or recommend treatment.

Is it a medical device?

Medora Scribe is documentation software. It does not diagnose and it is not a diagnostic device; the clinician makes every clinical decision.

Which allergy visits does Medora document?

New patient and follow-up visits, skin testing (prick, intradermal and patch), immunotherapy, asthma, and food and drug challenges each have an allergy visit template. The skin-test results the nurse records sit beside the drafted note.

How can a practice try it?

Start the 14-day self-serve trial with no card, or join as one of 20 founding practices: a free 30-day pilot on your own visits, set up with your team in one day.

See allergy AI in a real workflow.

A demo patient, from conversation to a signed, evidence-linked note.